SEATTLE, and SAN FRANCISCO, Sept. 20, 2018 /PRNewswire-PRWeb/ -- MCG Health, part
Cadalys Director of Product Development, Jon Tresko, and MCG Associate Director of Product Management, Marivie Lanter, RN, BSN, will present the breakout session, "Intelligent Care Management with Evidence-Based Guidelines," on Thursday, September 27 from 11:00 am to 11:20 am at the Moscone South, Partner Theater 1. This session will discuss how to continually optimize care planning and improve outcomes by leveraging evidence-based guidelines via Salesforce's workflow automation and analytics tools. Executives in healthcare and life science fields are strongly encouraged to attend.
In May 2018, MCG and Cadalys launched Cadalys Care (Informed by MCG) for Salesforce Health Cloud (available through the Salesforce AppExchange®). The solution makes evidence-based care guidance easily accessible and gives care providers a complete view of a patient's care journey, including current conditions and medications. Care team members can access daily task/patient prioritization dashboards, interact with other care managers via the Chatter tool, quickly identify patient progress using a timeline of events, and customize panels for high-level views of relevant information. Cadalys Care (Informed by MCG) also features a disease management component which includes assessments and care plans for chronic condition management and transitions of care, and tools to help clinicians determine appropriate levels and settings of care. In addition, Cadalys will also be premiering new versions of Cadalys Care three times per year (alongside major Salesforce releases) including tools for utilization management and triage chatbots.
The Dreamforce event is widely considered the largest single-vendor technology conference in the world. It brings together thousands of Salesforce users and partners to explore new ways to engage with its cloud-based CRM platform. Cadalys Care (Informed by MCG) will be featured in the Moscone South building (booth 1741) during the conference, and the main Salesforce Health Lodge booth will feature live demos of the Cadalys Care solution. Booth 1741 will also have additional information on integrations between MCG and Cadalys for post-acute and home care which deliver evidence-based guidelines and benchmarks to improve the patient journey outside hospital walls. You can learn more about the Dreamforce event by visiting https://www.salesforce.com/dreamforce/.
About Cadalys Cadalys works with the newest leading-edge Salesforce® technology to deliver superior solutions to its customers and clients through its multidimensional partnership with Salesforce. Being a Systems Integrator, Product Development Outsourcer and AppExchange partner, Cadalys brings a unique and well-rounded skillset to the table. As companies become more sophisticated and experienced purchasers of Salesforce implementation services, they demand consultants who have more than just an expertise in the technology. To truly succeed, consultants must have a business savvy and insight that matches their ability to develop and deploy complex technical solutions. Cadalys fills a unique role in the marketplace, complementing their Salesforce expertise with a rich business-centric approach and perspective. Anyone can deliver a project on time and on budget—Cadalys will ensure that your business initiative succeeds as well.
About MCG MCG, part of the Hearst Health network, helps healthcare organizations implement informed care strategies that proactively and efficiently move patients toward health. MCG's transparent assessment of the latest research and scholarly articles, along with our own data analysis, gives patients, providers and payers the vetted information they need to feel confident in every care decision, in every moment. For more information, visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.
About Hearst Health The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MedHOK, Hearst Health Ventures and the Hearst Health Innovation Lab (http://www.hearsthealth.com/). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 70 million home health visits and 3.2 billion dispensed prescriptions.
SOURCE MCG Health
Subscribe to our Free Newsletters!